Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Tamoxifen Promotes Axonal Preservation and Gait Locomotion Recovery after Spinal Cord Injury in Cats.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Cognitive impairment and cortical degeneration in neuromyelitis optica.
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
High-dose cyclophosphamide in the treatment of multiple sclerosis.
Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
Pain and multiple sclerosis: pathophysiology and treatment.
The nocebo effect: A clinicians guide.
Yoga for multiple sclerosis: a systematic review and meta-analysis.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
IgM antibody identifies good candidates for natalizumab
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
The gut microbiota and its correlations with the central nervous system disorders.
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis.

Pages